Notably, a study by Wang et al. revealed that EMP2 exhibits organ-specific functions in cancer pathogenesis, acting as an oncogene in hormone-related cancers such as human endometrial cancer and ovarian cancer while functioning as a tumor suppressor in urothelial cancer [16]. The gene discussed is EMP2; the disease is endometrial cancer.